REGENXBIO FY2026 EPS Estimate Increased by Leerink Partnrs
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2026 earnings per share (EPS) estimates for REGENXBIO in a research report issued on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will post earnings per share of ($1.65) for the year, up from their […]
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2026 earnings per share (EPS) estimates for REGENXBIO in a research report issued on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will post earnings per share of ($1.65) for the year, up from their […]
